MODULATION OF THERAPEUTIC RESPONSE AND PHARMACOKINETICS OF 5-FU BY P53 THROUGH REPRESSION OF THE PYRIMIDINE CATABOLIC GENE DIHYDROPYRIMIDINE DEHYDROG
$130,751FY2016Department of DefenseDOD
The Institute For Cancer Research
The Institute For Cancer Research